Literature DB >> 32558294

Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy.

Amrita Goyal1, Seth Lofgreen1, Evan Mariash2, Andrea Bershow3, Kevin J Gaddis1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32558294     DOI： 10.1111/dth.13725

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  3 in total

Review 1.  Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.

Authors:  Evan S Dellon; Dagmar Simon; Michael E Wechsler
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-12

2.  Haematologic-Related Malignancy-Induced Eosinophilic Dermatoses (He Remained): A Narrative Review.

Authors:  Bikash Ranjan Kar; Akash Agarwal
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

Review 3.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.